I went looking for the research on Protandim, since it sounded so amazing
In the case of many previous GLP-1 drugs, the reduction of calories, as a result of the drug, leads to an energy deficit, causing the body to burn muscle as a response
Choosing the right diluent is therefore not a side detail it is part of the experimental design
The strongest route-specific work uses oral delivery into inflamed gut tissue, not SubQ delivery for human skin. The evidence does not transfer cleanly across dose, route, or formulation

CrossRef CR1(+) tumor-associated macrophages orchestrate an immunosuppressive niche in hepatocellular carcinoma: a genetic and multi-omics dissection Zhengjian Wang, Zhe Wang, Xuda Ji, Liping Zhao, Kai Zheng, Wen Yu, Hanzhe Zhang, Hong Chang, Fangfeng Liu Journal of Translational Medicine .2026;[Epub] CrossRef BRSK2 accumulation mediated by TRIM28 accelerates hepatocellular carcinoma progression via activating the PI3K/AKT/mTOR signaling pathway Shengjin Han, Tan Liang, Cui Yang, Yunlong Xing, Jianzhong Ma, Zhengwu Zhou, Zixiang Chen, Yijun Zhao, Jiangming Chen, Fubao Liu Molecular and Cellular Biochemistry .2026;[Epub] CrossRef Molecular analysis of genes MICA , GPC3, PNPLA3, and TM6SF2 polymorphisms in patients of hepatocellular carcinoma Wenshuang Zou, Kashif Bashir, Rafia Batool, Maria Nasim, Hafiza Fakhira Ameer, Maryam Ali Nucleosides, Nucleotides & Nucleic Acids .2026